Assessing fidelity of treatment delivery in group and individual 12-step facilitation

作     者：Campbell, Barbara K. Manuel, Jennifer K. Manser, Sarah Turcotte Peavy, K. Michelle Stelmokas, Julija McCarty, Dennis Guydish, Joseph R. 

作者机构：Oregon Hlth & Sci Univ Dept Publ Hlth & Prevent Med Portland OR 97239 USA Univ Calif San Francisco Dept Psychiat San Francisco CA 94118 USA Univ Calif San Francisco Philip R Lee Inst Hlth Policy Studies San Francisco CA 94118 USA Univ Washington Alcohol & Drug Abuse Inst Seattle WA 98105 USA Univ Pacific Sch Profess Psychol Hillsboro OR 97123 USA 

出 版 物：《JOURNAL OF SUBSTANCE ABUSE TREATMENT》 (毒性物质滥用治疗杂志)

年 卷 期：2013年第44卷第2期

页      面：169-176页

核心收录：

学科分类：0402[教育学-心理学(可授教育学、理学学位）] 1007[医学-药学(可授医学、理学学位)] 1004[医学-公共卫生与预防医学(可授医学、理学学位)] 10[医学] 

基　　金：NIDA NIH HHS [T32 DA007250, R01 DA025600, UG1 DA015815, P50 DA009253, U10 DA015815] Funding Source: Medline National Institute on Drug Abuse [T32DA007250] Funding Source: NIH RePORTER 

主　　题：12-Step facilitation Treatment fidelity Coding system 

摘      要：Twelve step facilitation (TSF) is an emerging, empirically supported treatment, the study of which will be strengthened by rigorous fidelity assessment. This report describes the development, reliability and concurrent validity of the Twelve Step Facilitation Adherence Competence Empathy Scale (TSF ACES), a comprehensive fidelity rating scale for group and individual TSF treatment developed for the National Drug Abuse Treatment Clinical Trials Network study, Stimulant Abuser Groups to Engage in 12-Step. Independent raters used TSF ACES to rate treatment delivery fidelity of 966 (97% of total) TSF group and individual sessions. TSF ACES summary measures assessed therapist treatment adherence, competence, proscribed behaviors, empathy and overall session performance. TSF ACES showed fair to good overall reliability;weighted kappa coefficients for 59 co-rated sessions ranged from .31 to 1.00, with a mean of .69. Reliability ratings for session summary measures were good to excellent (.69-.91). Internal consistency for the instrument was variable (.47-.71). Relationships of the TSF ACES summary measures with each other, as well as relationships of the summary measures with a measure of therapeutic alliance provided support for concurrent and convergent validity. Implications and future directions for the use of TSF ACES in clinical trials and community treatment implementation are discussed. (C) 2013 Elsevier Inc. All rights reserved.